A humanized monoclonal antibody targeting Staphylococcus aureus
- 6 December 2004
- Vol. 22, S39-S43
- https://doi.org/10.1016/j.vaccine.2004.08.015
Abstract
No abstract availableKeywords
This publication has 23 references indexed in Scilit:
- In Vitro Activity of Recombinant Lysostaphin against Staphylococcus aureus Isolates from Anterior Nares and BloodAntimicrobial Agents and Chemotherapy, 2003
- Lysostaphin Disrupts Staphylococcus aureus and Staphylococcus epidermidis Biofilms on Artificial SurfacesAntimicrobial Agents and Chemotherapy, 2003
- Infection with Vancomycin-ResistantStaphylococcus aureusContaining thevanAResistance GeneNew England Journal of Medicine, 2003
- The Impact of Surgical-Site Infections Following Orthopedic Surgery at a Community Hospital and a University Hospital Adverse Quality of Life, Excess Length of Stay, and Extra CostInfection Control & Hospital Epidemiology, 2002
- BacteriophagesBioDrugs, 2002
- Population‐Based Incidence and Characteristics of Community‐OnsetStaphylococcus aureusInfections with Bacteremia in 4 Metropolitan Connecticut Areas, 1998The Journal of Infectious Diseases, 2001
- The Impact of Surgical-Site Infections in the 1990s: Attributable Mortality, Excess Length of Hospitalization, And Extra CostsInfection Control & Hospital Epidemiology, 1999
- Nosocomial infections in medical intensive care units in the United StatesCritical Care Medicine, 1999
- Nosocomial Infections in Surgical Patients in the United States, January 1986-June 1992Infection Control & Hospital Epidemiology, 1993
- Hospital Reimbursement Patterns Among Patients With Surgical Wound Infections Following Open Heart SurgeryInfection Control & Hospital Epidemiology, 1990